Measles and the MMR Vaccine – Setting the Record Straight

With the current media frenzy and fear mongering over a few dozen cases of the measles, it is astonishing to note that very few mainstream reports provide balance by also reporting on the damage being done by the MMR vaccine.

The CDC continues to brazenly lie about the MMR, as evidenced in a media teleconference held on 1/29/15 where CDC representative Ann Schuchat stated: “MMR vaccine is safe and effective”.

But facts show the MMR is not safe or effective. Frankly, we have no idea how many people are harmed or killed by the vaccine, nor do we know which people the vaccine may provide temporary disease protection for. The “authorities” don’t know, either – despite their claims.

IS THE MMR VACCINE SAFE?

The Cochrane Collaboration, which evaluates the strength of scientific evidence for the safety and effectiveness of medical interventions, examined published studies about MMR vaccine safety and concluded that  “The design and reporting of safety outcomes in MMR vaccine studies …, are largely inadequate. The evidence of adverse events following immunisation with MMR cannot be separated from its role in preventing the target diseases.” [i]

17 years ago, a study published in the journal of the American Academy of Pediatrics showed that measles-containing vaccines were definitely NOT safe for every child.

Acute encephalopathy followed by permanent brain injury or death associated with further attenuated measles vaccines: a review of claims submitted to the National Vaccine Injury Compensation Program.

RESULTS: A total of 48 children, ages 10 to 49 months, met the inclusion criteria after receiving measles vaccine, alone or in combination. Eight children died, and the remainder had mental regression and retardation, chronic seizures, motor and sensory deficits, and movement disorders. The onset of neurologic signs or symptoms occurred with a nonrandom, statistically significant distribution of cases on days 8 and 9. No cases were identified after the administration of monovalent mumps or rubella vaccine.

CONCLUSIONS: This clustering suggests that a causal relationship between measles vaccine and encephalopathy may exist as a rare complication of measles immunization.

Pediatrics, Vol. 101 No. 3 March 1, 1998 pp. 383 -387 http://pediatrics.aappublications.org/content/101/3/383.abstract

(Although the authors of this paper use the term “rare complication” there is no way to know how many individuals were harmed or killed by the vaccine, as the study only looked at claims that were filed in the NVICP)

In a 10-year study of adverse reactions from MMR in adults, VAERS (the Vaccine Adverse Events Reporting System) received 3,175 US reports after MMR vaccine in adults. Of these, 168 (5%) were classified as serious, including 7 reports of death.

http://www.ncbi.nlm.nih.gov/pubmed/25637587

This study also identified 131 reports of MMR vaccine administered to pregnant women, of which 38% experienced an adverse reaction.

One Canadian study found “There are significantly elevated risks of emergency room visits” following the MMR vaccination. [ii]

The package insert is seldom presented to consumers, so here is a link to the package insert for the M-M-R® II vaccine:

http://www.merck.com/product/usa/pi_circulars/m/mmr_ii/mmr_ii_pi.pdf

Among the list of side effects are:

Panniculitis; atypical measles; fever; syncope; Vasculitis ; Pancreatitis; diarrhea; vomiting; parotitis; nausea; Diabetes mellitus; Thrombocytopenia; purpura; regional lymphadenopathy; leukocytosis; Anaphylaxis; Arthritis; arthralgia; myalgia; Encephalitis; encephalopathy; measles inclusion body encephalitis (MIBE); subacute sclerosing panencephalitis (SSPE); Guillain-Barré Syndrome (GBS); acute disseminated encephalomyelitis (ADEM); transverse myelitis; febrile convulsions; afebrile convulsions or seizures; ataxia; polyneuritis; polyneuropathy; ocular palsies; paresthesia; Pneumonia; pneumonitis; sore throat; cough; rhinitis; Stevens-Johnson syndrome; erythema multiforme; urticaria; rash; measles-like rash; pruritis; Nerve deafness; otitis media; Retinitis; optic neuritis; papillitis; retrobulbar neuritis; conjunctivitis; Epididymitis; orchitis; Death.

Senior CDC scientist-turned whistleblower William Thompson revealed in August 2014 that he and his co-authors intentionally omitted a subset of children in a 2004 study on the MMR vaccine. http://www.rescuepost.com/files/william-thompson-statement-27-august-2014-3.pdf

The study was designed to determine if earlier administration of the MMR vaccine resulted in a higher rate of autism. Original study results showed a significantly higher rate of autism in children who got the MMR before 36 months of age, and the association was highest among African-American boys. After Thompson and his co-authors deliberately removed a subset of African-American boys from the dataset (which completely defied study protocol), the statistical significance of an increased rate of autism was removed. And that altered study is what the CDC submitted for publication.

With William Thompson finally achieving whistleblower status and protection, the congressional investigation into CDC malfeasance related to MMR vaccine safety studies will be moving forward soon. But even in the absence of confirmed fraud at the CDC, it simply cannot be said that the MMR vaccine is “safe”.

In 1986, Congress passed the National Childhood Vaccine Injury Act, which shielded drug companies selling vaccines, and doctors giving them, from most vaccine injury lawsuits. The law set up a federal Vaccine Injury Compensation Program (VICP), and so far nearly $3 billion dollars has been awarded to victims of vaccine injury. To date, 357 families have been compensated by the federal court for death, brain damage or permanent disability from the MMR vaccine alone, and this continues, averaging fourteen families every year.

In the years 2009 through 2014 there were zero measles deaths in the U.S. but the National Vaccine Injury Compensation Program compensated five families when their children died after receiving vaccines that included the live measles vaccine*.

2009 – Natural Parents of ERICK SANTIAGO, JR., Decedent, Petitioners ADEENA SANTIAGO and ERICK SANTIAGO, SR., allege that the measles-mumps-rubella (“MMR”) and varicella vaccines administered to Erick on November 20, 2008, and the diphtheria-tetanus acellular-pertussis (“DTap”) and pneumococcal conjugate (“PCV7”) vaccines administered to Erick on May 21, 2009, exacerbated his pre-existing reactive airway disease and asthma, resulting in, or substantially contributing to his death on May 29, 2009. A lump sum of $25,000.00, in the form of a check payable to petitioners, as administrators/executors of Erick’s estate…http://www.uscfc.uscourts.gov/sites/default/files/opinions/CAMPBELL-SMITH.SANTIAGO.7.19.2012.pdf

2009 – (Attachment) KRISTEN RIDL, parent of S.M., deceased, Kristen Murdock (petitioner) filed a petition on behalf of her daughter, S.M., pursuant to the National Vaccine Injury Compensation Program.2 42 U.S.C. §§ 300aa-1 to -34 (2006). Petitioner alleged that S.M. suffered an encephalopathy and later died as a result of her receipt of Hepatitis A, Varicella, and Measles-Mumps-Rubella (“MMR”) vaccines on January 21, 2009. A lump sum of $170,000.00 in the form of a check payable to petitioner as guardian/conservator of S.M.’s estate. This amount represents compensation for all damages that would be available under 42 U.S.C. § 300aa-15(a).

2010 11-356V • APRIL L. GARTON and JEREMIAH R. CASMIRE, SR., natural parents of Jeremiah R. Casmire, Jr., deceased V. SECRETARY OF HEALTH AND HUMAN SERVICES April L. Garton and Jeremiah R. Casmire, Sr., filed a petition for compensation under the National Vaccine Injury Compensation Program, alleging that their son, Jeremiah Casmire, Jr., suffered a hypoxic/ischemic insult encephalopathy, which was caused-in-fact by the MMR vaccine he received on April 19, 2010, and died as a sequelae of the encephalopathy. I award petitioners a lump sum payment of $250,000.00 in the form of a check payable to petitioners, April L. Garton and Jeremiah R. Casmire, Sr. This amount represents compensation for all damages that would be available under § 300aa-15(a). http://www.uscfc.uscourts.gov/sites/default/files/opinions/VOWELL.GARTON102611_0.pdf

20111:13-vv-00409 • DAHL et al v. SECRETARY OF HEALTH AND HUMAN SERVICES Dalan and Elizabeth Dahl (petitioners) filed a petition on behalf oftheir daughter, LD, pursuant to the National Vaccine Injury Compensation Program.. Petitioners alleged that LD received a measles, mumps, and rubella (“MMR”) vaccine on June 6, 2011, and thereafter developed symptoms that led to her death on June 18, 2011. Informed by respondent’s concession that an award of damages is appropriate, the undersigned finds that petitioners are entitled to compensation under the Vaccine Act. A lump sum of $250,000.00, in the form of a check payable to petitioners. https://ecf.cofc.uscourts.gov/cgi-bin/show_public_doc?2013vv0409-25-0

2013 14-683 • R.T., et al v. SECRETARY OF HEALTH AND HUMAN SERVICES Filed 11/21/2014 Public Decision – Damages Decision Based on Proffer, conceded entitled to compensation. MMR, Varicella, Hib, and pneumococcal vaccines received on July 10, 2013; Death, payment of $500,000.00 and $600,394.22 to NM Medicaid lien https://ecf.cofc.uscourts.gov/cgi-bin/show_public_doc?2014vv0683-40-0

  • The last death in the state of Minnesota with any relation to the measles was a toddler who perished from the measles VACCINE – and that was 24 years ago!

*This is likely only a fraction of the actual number of deaths, as very few claims are successful in proving causation in the NVICP. Many infant deaths are ruled as “SIDS”, without proper investigation into parental claims. When you also factor in the hundreds of compensated claims for permanent vaccine-induced brain damage, and the additional thousands of parental reports of such, ask yourself:

What is an acceptable price for preventing measles?

Death from a disease or a vaccine is devastating for any family.

First, do no harm

IS THE MEASLES VACCINE EFFECTIVE?

“As for any vaccine, vaccination with M-M-R II may not result in protection in 100% of vaccinees.”

From package insert: http://www.merck.com/product/usa/pi_circulars/m/mmr_ii/mmr_ii_pi.pdf

In 2014, “…About 17 percent of U.S. (measles) cases this year (2014) were vaccinated. Health officials say that although the vaccine is very effective, it’s not perfect. “

http://www.foxnews.com/health/2014/04/25/deaths-from-measles-outbreak-may-be-inevitable-as-cases-surge-in-us/

  • In fact, in every measles outbreak in recent years, there have been cases confirmed in vaccinated individuals. And in the recent mumps outbreaks, the majority of the cases had been vaccinated with MMR.
  • Merck, the manufacturer of the MMR, is in the middle of a controversy following disturbing allegations of wrongdoing. In the case of United States v. Merck & Co., claims have been made by two former Merck scientists that Merck “fraudulently misled the government and omitted, concealed, and adulterated material information regarding the efficacy of its mumps vaccine in violation of the FCA [False Claims Act].”  The whistleblowers claim the fraud was committed in order to produce test results that would meet the FDA’s requirement that the mumps vaccine was 95% effective. Although Merck attempted to get the case thrown out, a judge dismissed Merck’s objections to the case proceeding, and determined the whistleblowers had plausible grounds on all of the claims lodged against Merck.  The situation and charges are outlined in more detail here:

http://www.huffingtonpost.ca/lawrence-solomon/merck-whistleblowers_b_5881914.html

Vaccine Safety Council of Minnesota encourages consumers to educate themselves rather than blindly accepting the cavalier statements of public health officials who disregard and downplay the horrific, well-documented vaccine injuries. There is no informed consent when one is not fully informed.

[1] Adverse Events following 12 and 18 Month Vaccinations: a Population-Based, Self-Controlled Case Series Analysis

Kumanan Wilson1,2,3,4*, Steven Hawken2, Jeffrey C. Kwong5, Shelley Deeks6, Natasha S. Crowcroft6, Carl

Van Walraven1,2,3, Beth K. Potter2,3, Pranesh Chakraborty4,8, Jennifer Keelan7, Michael Pluscauskas4,

Doug Manuel2,3,9


[i] http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD004407/frame.html
Cochrane Database of Systematic Reviews 2005, Issue 4  “Vaccines for Measles, Mumps and Rubella in Children”  Demicheli V,  Jefferson T,  Rivetti A,  Price D

[ii] Adverse Events following 12 and 18 Month Vaccinations: a Population-Based, Self-Controlled Case Series Analysis

Kumanan Wilson1,2,3,4*, Steven Hawken2, Jeffrey C. Kwong5, Shelley Deeks6, Natasha S. Crowcroft6, Carl

Van Walraven1,2,3, Beth K. Potter2,3, Pranesh Chakraborty4,8, Jennifer Keelan7, Michael Pluscauskas4,

Doug Manuel2,3,9

1 Department of Medicine, Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Canada, 2 Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Canada, 3 Department of Epidemiology and Community Medicine, University of Ottawa, Ottawa, Canada, 4 Newborn Screening Ontario, Children’s Hospital of Eastern Ontario, Ottawa, Canada, 5 Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada, 6 Ontario Agency for Health Protection and Promotion, Toronto, Ontario, Canada, 7 Dalla Lana School of Public Health, University of Toronto, Toronto, Canada, 8 Department of Pediatrics, University of Ottawa, Ottawa, Canada, 9 Department of Family Medicine, University of Ottawa, Ottawa, Canada

Results: Four to 12 days post 12 month vaccination, children had a 1.33 (1.29–1.38) increased relative incidence of the combined endpoint compared to the control period, or at least one event during the risk interval for every 168 children vaccinated. Ten to 12 days post 18 month vaccination, the relative incidence was 1.25 (95%, 1.17–1.33) which represented at least one excess event for every 730 children vaccinated. The primary reason for increased events was statistically significant elevations in emergency room visits following all vaccinations. There were non-significant increases in hospital admissions. There were an additional 20 febrile seizures for every 100,000 vaccinated at 12 months. Conclusions: There are significantly elevated risks of primarily emergency room visits approximately one to two weeks following 12 and 18 month vaccination. Future studies should examine whether these events could be predicted or prevented.